derma plus cream
shelys pharmaceuticals limited plote no. 696, new bagamoyo road, mwenge. p. o. - betamethasone dipropionate bp, neomycin sulphate - cream - betamethasone dipropionate bp 0.064%w/w, neomycin - combinations of moderately potent corticosteroids
laeovate n drops ear/eye drops, solution
laboratory & allied ltd p.o box 42875 gpo 00100 nairobi, kenya - betamethasone sodium phosphate neomycin sulphate - ear/eye drops, solution - betamethasone sodium phosphate bp 0.1 % w/v - otological anti-infectives
betamethasone sodium phosphate and betamethasone acetate injection, suspension
remedyrepack inc. - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency. synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance.
betacorten g ointment
trima israel pharmaceutical products maabarot ltd - betamethasone as valerate; gentamicin as sulfate - ointment - betamethasone as valerate 0.1 %w/w; gentamicin as sulfate 0.1 %w/w - betamethasone - betamethasone - for local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.
betacorten g cream
trima israel pharmaceutical products maabarot ltd - betamethasone as valerate; gentamicin as sulfate - cream - betamethasone as valerate 0.1 %w/w; gentamicin as sulfate 0.1 %w/w - betamethasone and antibiotics - betamethasone and antibiotics - for local treatment of inflammatory dermatoses and allergic skin conditions complicated by infections.
betnesol-n 0.1% w/v, 3500 iu/ml eye, ear and nasal drops, solution
rph pharmaceuticals ab - neomycin sulfate; betamethasone sodium phosphate - ear/eye/nasal drops, solution - 0.1% w/v 3500 international unit(s)/millilitre - corticosteroids and antiinfectives in combination; betamethasone and antiinfectives
betamethasone dipropionate ointment
prasco laboratories - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - augmented betamethasone dipropionate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. augmented betamethasone dipropionate ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. risk summary there are no available data on augmented betamethasone dipropionate ointment use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy. advise pregnant women that augmented betamethasone dipropionate ointment may increase the risk of having a low birthweight infant and to use augmented betamethasone dipropionate ointment on the smallest
betamethasone sodium phosphate and betamethasone acetate injection, suspension
american regent, inc. - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency. synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance. gastrointesti
dawavate g ointment
dawa limited p.o. box 16633-00620 nairobi. - betamethasone valerate & gentamicin sulphate - ointment - betamethasone (as valerate) usp 0.1%w/w & - combinations of potent corticosteroids with
tacine eye/ear drops eye drops, solution
neomycin sulphate 0.5%,betamethasone sodium - eye drops, solution - neomycin sulphate 0.5%,betamethasone sodium - ophthalmological and otological preparation: